arrow: psma-targeted radioligand therapy plus enzalutamide in mcrpc
Published 3 years ago • 129 plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
1:36
advances in psma-targeted therapy for prostate cancer
-
2:37
arches trial: enzalutamide plus adt for mhspc
-
1:37
recent advances in mhspc: 177lu-psma-617, propel and biomarker-directed strategies
-
2:04
radioligand therapy advancements in prostate cancer
-
4:42
psma-targeted imaging with 18f-dcfpyl-pet/ct in patients with prostate cancer
-
2:25
phase i trial of arx517, an anti-psma adc, in mcrpc
-
1:49
radioligands in the future of prostate cancer treatment
-
6:49
ramp: phase ib study of rucaparib & enzalutamide in mcrpc
-
1:31
investigating prognostic markers for os with lupsma treatment in mcrpc
-
2:35
pca commentary may 2021 - psma targeted radioiigand therapy for metastatic prostate cancer
-
3:20
pcss-prostate cancer: cluster therapy and clinical trials
-
![upfront [177lu]lu-psma-617 radioligand therapy prior to radical prostatectomy in men with hr pc](https://i.ytimg.com/vi/BgbkDD3Orew/mqdefault.jpg)
4:28
upfront [177lu]lu-psma-617 radioligand therapy prior to radical prostatectomy in men with hr pc
-
26:28
radiogland therapy optimization of prostate specific membrane antigentargeted radiation
-
1:30
dr. sartor on the vision trial in mcrpc
-
1:13
prostate cancer trial
-
2:25
key questions for prostate cancer patients to ask before joining a clinical trial
-
5:57
psma f18 pylarify piflufolastat radioligand theragnostics for prostate cancer
-
4:56
improving the prognosis for patients with mcrpc
-
2:52
when should advanced prostate cancer patients consider a clinical trial?